Standing notice

Terms of use

A short, plainly written agreement between this publication and its readers.

I. The nature of this publication

Somnipeptide is an independent editorial review. What you find here — the evidence summaries, the provider rankings, the notes and sources — is offered as reading, not as a service rendered to you, and not as a contract between us. By reading on, you accept the terms set out below in the spirit in which they are written: plainly, and in good faith.

II. Information, not advice

Everything published here is for general information. It is not medical, clinical, or professional advice, and it is no substitute for a consultation with a licensed clinician who knows your history. Sermorelin and related peptides are prescription matters; compounded preparations are not FDA-approved. Decisions about your health belong with you and your physician — never with a web page.

III. Affiliate links & independence

Some links carry an affiliate or referral arrangement, and a commission may be paid to us when a reader acts on one. This funds the work; it does not steer it. Our conclusions follow the evidence and our editorial judgement, as described in full in our affiliate & advertising disclosure.

IV. Accuracy & the limits of our diligence

We verify prices, programs, and claims against primary sources at the time of writing, and we date our reviews. Even so, the field moves and third-party sites change without notice. We make no warranty that the material is complete, current, or free of error, and we are not liable for any loss arising from reliance on it. Confirm anything that matters with the provider or clinician directly before acting.

V. The words and the artwork

The text, rankings, illustrations, and design of Somnipeptide are our own work. You are welcome to quote a passage with attribution and a link; please do not republish substantial portions, or pass the material off as your own.

VI. Changes to these terms

We may revise these terms as the publication grows. The current version always lives at this address; continued reading after a change is taken as acceptance of it. Questions are welcome through the contact details on our about page.